发明名称 Oxadiazoles as modulators of metabotropic glutamate receptor-5
摘要 Oxadiazoles compounds of formula (I), wherein P, Q, X1, X2, X3, X4, R, R1, R2, R3, R4, R5, R6, R7, m, n, o, p and q are defined as in the specification, a process for their preparation and new intermediates prepared therein and pharmaceutical formulations containing these compounds are disclosed. These compounds of formula (I) are suitable as modulators of metabotropic glutamate receptor-5 (mGluR5) and are used for treating mGluR5 receptor mediated disorders such as neurological disorders, psychiatric disorders and chronic and acute pain disorders.
申请公布号 NZ538339(A) 申请公布日期 2007.01.26
申请号 NZ20030538339 申请日期 2003.08.08
申请人 ASTRAZENECA AB;NPS PHARMACEUTICALS, INC 发明人 WENSBO, DAVID;XIN, TAO;STEFANAC, TOMISLAV;ARORA, JALAJ;EDWARDS, LOUISE;ISAAC, METHVIN;SLASSI, ABDELMALIK;STORMANN, THOMAS M;MCLEOD, DONALD A;KERS, ANNIKA;MALMBERG, JOHAN;OSCARSSON, KARIN
分类号 A61P25/00;C07D261/08;C07D261/14;C07D271/06;C07D271/07;C07D271/10;C07D271/107;C07D271/113;C07D413/04;C07D413/06;C07D413/10;C07D413/14;(IPC1-7):A61K31/424 主分类号 A61P25/00
代理机构 代理人
主权项
地址